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Background: The purpose of the study was to evaluate in a sample of insulin-treated diabetic patients, with type 1
or type 2 diabetes, the psychometric characteristics of the Italian version of the DEPS-R scale, a diabetes-specific
self-report questionnaire used to analyze disordered eating behaviors.
Methods: The study was performed on 211 consecutive insulin-treated diabetic patients attending two specialist
centers. Lifetime prevalence of eating disorders (EDs) according to DSM-IV and DSM-5 criteria were assessed by
means of the Module H of the Structured Clinical Interview for DSM IV Axis I Disorder and the Module H modified,
according to DSM-5 criteria. The following questionnaires were administered: DEPS-R and the Eating Disorder
Inventory – 3 (EDI-3). Test/retest reproducibility was assessed on a subgroup of 70 patients. The factorial structure,
internal consistency, test-retest reliability and concurrent validity of DEPS-R were assessed.
Results: Overall, 21.8% of the sample met criteria for at least one DSM-5 diagnosis of ED. A “clinical risk” of ED was
observed in 13.3% of the sample. Females displayed higher scores at DEPS-R, a higher percentage of at least one
diagnosis of ED and a higher clinical risk for ED. A high level of reproducibility and homogeneity of the scale were
revealed. A significant correlation was detected between DEPS-R and the 3 ED risk scales of EDI-3.
Conclusions: The data confirmed the overall reliability and validity of the scale. In view of the significance and
implications of EDs in diabetic patients, it should be conducted a more extensive investigation of the phenomenon
by means of evaluation instruments of demonstrated validity and reliability.
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The management of diabetes patients needs to pay care-
ful attention to the food they consume, to refer to nutri-
tional tables, to apply precision in the preparation of
portions and to constantly monitor calorie intake on the
basis of insulin dosage. However, this focus on food,
fundamental in controlling the disease, places diabetic
patients at increased risk of developing EDs. However,
EDs appear to be harder to identify in this category of
patients, and distinguishing between a healthy eating
regime and a disturbed behavior may prove to be an ar-
duous task [1]. Accordingly, considerable interest has
been shown in the in-depth analysis of the significance
and characteristics of clinical entities widely referred to
as “Disturbed Eating” or “Disturbed Eating Behaviors”
(DEB), which are generally considered borderline cat-
egories of ED made up of symptoms that have not yet
reached a level of severity and frequency to allow them
to be classified as EDs [2]. Frequently a DEB will be
manifested only as a change in the eating pattern of dia-
betic patients [3]. Reports present in the literature are
largely in agreement over the high rates of EDs, DEB,
binge eating and bulimic symptoms observed in patients
with both type 1 [4–13], and type 2 diabetes [8, 14],
reporting generally higher rates of EDs in diabetic patients
compared to the general population [1, 4, 6, 7, 13, 15]. A
recent review and meta-analysis of 6 ED studies and 8
focusing on DEB, reported a higher prevalence for both
conditions amongst adolescents and young adults with
type 1 diabetes than in age-matched non-diabetic controls
[13]. Jones et al. [7] highlighted the presence of EDs in
10% of adolescents with type 1 diabetes aged between 12
and 19 years, versus 4% of healthy age-matched individ-
uals. Neumark-Sztainer et al. [10] found high rates of DEB
(37.9% in females and 15.9% in males) in adolescents and
young adults with type 1 diabetes aged from 12 to 21 years.
These EDs tend to first present during adolescence and
persist into adulthood, particularly if left untreated [5].
The fact that the vast majority of studies are focused on
young females, and that studies regarding adults with dia-
betes are somewhat scarce, makes it highly likely that a
large number of cases of EDs in this population may be
underestimated and under-diagnosed [16]. Within the
range of specific DEBs in insulin-treated diabetic patients,
insulin manipulation is of particular interest. This practice,
defined by several authors as “diabulimia”, may be viewed
as the analog of an ED in which adolescents and young
adults, mostly females, with insulin-treated diabetes
deliberately omit to administer insulin, manipulating the
prescribed dose with the aim of losing weight or preventing
weight gain [17]. Those in charge of diabetes management
have long acknowledged this practice, and prevalence rates
are so high to suggest the need to recognize diabulimia as
an overt psychiatric disorder with specific diagnosticcriteria, suitable for inclusion as a stand-alone clinical entity
in the classifications of psychiatric diagnostic manuals [18].
The restriction or omission of insulin to control body
weight is considered a form of purging available solely to
diabetic patients, compromises control of the metabolism
and determines an increased risk of morbidity and
mortality [19]. Some of the more commonly observed
alarm signals, which may point to the presence of insulin
manipulation, include: persistently high glycosylated
hemoglobin levels, frequent referral to the emergency
department for diabetic ketoacidosis, tendency towards
thinness, dissatisfaction with personal body image, hyper-
glycemia with frequent candidiasis or urinary infections,
and poor compliance with check-up visits and treatments
for diabetes [17]. The first article reporting on insulin pur-
ging in a diabetic patient was published in 1983 [20]. Subse-
quently, an increasing number of studies have investigated
the presence of insulin omission in samples of diabetic pa-
tients, attempting to estimate the prevalence and diffusion
of this specific behavior. The findings demonstrate how
prevalence increases with age, rising from 1% in pre-
adolescence [4], to 11–14% during the initial stages of
adolescence [7, 21], reaching 27–39% in late adolescence
and early adulthood [5, 21, 22]. A study conducted by
Ackard et al. on 143 adolescents, 73 males and 70 females,
affected by type 1 diabetes, found that 10.3% of females
omitted to administer insulin, and 7.4% administered a
lower dose, in order to control their weight, versus 1.4% of
males [23]. Another significant aspect currently subjected
to increasing debate relates to the efficacy of traditional
screening tools for ED in this patient population. Powers
et al. reported how both the Eating Disorders Examination
Questionnaire (EDE-Q) and the Eating Disorders Inven-
tory, version 3 (EDI – 3), when administered to subjects
with diabetes, may provide scarcely reliable results [24]. In-
deed, due to the emphasis placed on the careful monitoring
of food intake and weight control during diabetes treat-
ment, several items may be misinterpreted by patients
resulting in a consequent increased risk of both false posi-
tives and false negatives. To date, the only two specific
questionnaires for use in investigating ED in the diabetic
population are the Diagnostic Survey for Eating Disorders
(DSED) and the Diabetes Eating Problems Survey [DEPS],
both of which include items specifically correlated to
diabetes, such as insulin manipulation for the purpose of
weight control. The DSED is a self-evaluation tool compris-
ing 12 sections, although its use as a structured interview
has also been suggested [25]. A modified version of this
scale, the DSED – M, has subsequently been developed
[22, 26]. The DEPS is a questionnaire comprising 28
items developed in 2001 by Antisdel et al. [27]. Initially
tested on adult female patients with type 1 diabetes over
the age of 18 years, the scale has subsequently been used
as an evaluation tool in populations of adolescent diabetic
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shortened version of DEPS, DEPS-R, comprising 16 items,
in a sample of 112 adolescents with type 1 diabetes, 49
males and 63 females, in an age range of 13–19 years [29].
The DEPS-R scale, developed as a tool capable of rapidly
screening for EDs in a pediatric population with type 1
diabetes, is currently recognized as a valid screening tool
for use in identifying at-risk EDs in this patient population
[1, 16, 29–32]. In view of the relevance of EDs in diabetic
subjects and the associated health risks, the need for fur-
ther in-depth studies to be conducted on an extended
clinical sample of diabetic patients, both children and
adults, with both type 1 and type 2 diabetes using specific
questionnaires of demonstrated validity and reliability,
should be underlined. Considering these premises, the
purpose of the present study was to validate the Italian
version of the DEPS-R scale in a sample of insulin-treated
male and female subjects with type 1 and type 2 diabetes
aged from 13 to 55 years. The authors aimed to overcome
some of the more significant limitations of previous
validation studies, extending validation to adults and to
subjects affected by type 2 diabetes, and analyzing the
DEPS-R scale in relation to a self-administered specific
tool for the assessment of EDs accompanied by the use of
a structured clinical interview for the diagnosis of EDs
according to DSM-IV and DSM 5 criteria [29, 31, 32].
Taking into account the high prevalence and implica-
tions of comorbidity between diabetes and EDs, and the
singular means of manifestation of EDs in diabetic sub-
jects, the availability of specific screening tools of proven
validity is crucial in facilitating the development of timely
and effective multidisciplinary interventions aimed at min-
imizing the short and long-term risk of complications.
Methods
A cross-sectional study was performed in a representa-
tive sample of insulin-treated diabetic patients with type
1 or type 2 diabetes aged from 13 to 55 years. An
unselected sample of consecutive insulin-treated diabetic
patients attending two specialist centers for the diagno-
sis and treatment of diabetes over a 4-month period was
assessed. These centers usually provide a global medical
and psychological evaluation based on a multidisciplin-
ary approach. When necessary, psychological support or
psychiatric interventions are provided. The data used for
this study derived from the routine assessment of psy-
chopathology, by means of a structured clinical interview
and specific questionnaires used to assess EDs, in the
diabetic patients attending the specialist centers. Resi-
dents in psychiatry conducted the interviews, after
having been trained in the use of the instrument by a se-
nior psychiatrist (FP). Inter-rater reliability, evaluated
using Cohen’s K before starting the study, remained sub-
stantial (K > 0.80). The study group was made up of 211participants (13–55 years old; 108 males, 103 females),
who met the above inclusion criteria.
Socio demographic data, medical history and clinical
data were collected by means of a structured interview.
Lifetime prevalence of EDs according to DSM-IV and
DSM-5 criteria were assessed by means of the Module H
of the Structured Clinical Interview for DSM IV Axis I
Disorder (SCID-I, Research Version, Non-Patient Edition)
[33] and the Module H modified, according to DSM-5 cri-
teria. The rationale for performing diagnosis using either
DSM IV or DSM-5 criteria was related to the acknowl-
edged increased ability of DSM-5 criteria to identify the
presence of an ED and to formulate a “specified ED
diagnosis”, thus reducing the rate of “non – specified ED
diagnosis” [34].
The following questionnaires were administered:
DEPS-R [29] and the EDI-3 [35]. Test/retest reproducibil-
ity of DEPS-R was evaluated on a subgroup of 70 patients
who filled the questionnaire in twice at approximately
one-month intervals.
Instruments
DEPS-R
DEPS-R is a diabetes-specific measure of DEB. The in-
strument is self-administered and composed of 16 items
on a 6-point Likert, ranging from 0 to 5, in relation to
frequency of the behavior (0 = never; 1 = rarely;
2 = sometimes; 3 = often; 4 = usually; 5 = always). It can
be completed in less than 10 min. Higher scores indicate
more DEB. The original instrument comprised 28 items
but it was lately revised and shortened to the DEPS-R by
Markowitz et al. [29]. The original DEPS-R was found to
have good psychometric properties in two different sam-
ples of young people (11–19 years) with type 1 diabetes
[29, 32]. More recently, the German version of the scale
was also found to have good psychometric properties in
a sample of young people, aged 11–19 years, with type 1
diabetes [31]. Relating to the aim of this study, a bilin-
gual psychiatrist, with expertise in the area of ED, trans-
lated the original English version of the scale into Italian.
A bilingual native English translator, blind to the original
version of the tool, later back translated the scale into
English. A high degree of similarity between the English
translation and the original version was found. (See
Additional file 1 for a copy of the Italian version of the
questionnaire).
EDI-3
EDI-3 is a self-administered scale created in order to
identify subjects at risk of developing an ED. The ques-
tionnaire analyzes psychological traits and key symptoms
considered relevant in the development and maintenance
of EDs. It is composed of 91 items with a choice of 6 an-
swers, based on frequency of the behavior (A = always;
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F = never), 12 primary scales (3 ED risk scales, 9 psycho-
logical scales) and six composite scores. High scores at ED
risk scales (“Drive for Thinness”, DT; “Bulimia”, B; “Body
Dissatisfaction”, BD), are linked to an increased risk of de-
veloping an ED. At each scale, a percentile score ranging
from 70° to 85° and a percentile score exceeding 85°
identify, respectively, the presence of a clinical and a
high clinical risk in the area evaluated. The Eating
Disorder Risk Composite (EDRC) score derives from
a combination of the three ED risk scales and pro-
vides a global measure of ED risk and of concerns
with food and body weight.Module H of the SCID-I
Lifetime prevalence of ED according to DSM-IV and
DSM-5 criteria were assessed by means of the Module H
of the Structured Clinical Interview for DSM IV Axis I
Disorder (SCID-I, Research Version, Non-Patient Edition)
[33] and the Module H modified, according to DSM-5
criteria. It was possible to investigate the following
diagnostic categories: Anorexia Nervosa and Bulimia
Nervosa according to DSM-IV and DSM-5 criteria,
Binge Eating Disorder according to DSM-5 criteria,
Eating Disorder Not Otherwise Specified according to
DSM-IV criteria, Unspecified Eating Disorder and
Other Specified Eating Disorder according to DSM-5
criteria (the modified version of Module H is available
from authors).Statistical analyses
To retest construct validity of the Italian version of
DEPS-R, a Confirmatory Factor Analysis was performed
[36]. A value of commonality was calculated for each item.
Intraclass correlation coefficient (ICC) was used to estimate
test-retest reliability. Internal consistency of the DEPS-R
and EDI-3 scales were evaluated by Cronbach’s Alpha coef-
ficient. Concurrent validity was studied by correlating the
DEPS-R scale with EDI-3 by means of Pearson’s correlation
coefficient. The incremental validity of DEPS-R and EDI-3
scales (predictor variables) versus the dichotomous variable
DSM-5 (criterion variable) was assessed by means of
hierarchical logistic regression [37, 38] using statistical
package R. A correlation between scores obtained at
DEPS-R and at EDI-3 for EDCR and relevant clinical
variables was carried out using Pearson’s coefficient of
linear correlation for continuous scales. Continuous
and categorical variables were compared using, as ap-
propriate, Mann-Whitney test, Pearson’s chi-squared
test and z-test. Statistical significance was set at
p < 0.005. Data analysis was carried out using SPSS
software - version 20.0, LISREL version 8.80 and R
Software version 3.3.0.Results
Characteristics of the study population
The sample studied included 211 insulin-treated diabetic
patients, 192 patients with a type 1, 19 patients with a
type 2 diabetes, 108 males and 103 females, with a me-
dian age of 38 years (13–55 years old), a median Body
Max Index (BMI) of 24 and a median score at DEPS-R
of 12 (Table 1). Overall, 21.8% of the sample met criteria
for at least one DSM-5 diagnosis of ED, 12.8% of the
sample met criteria for at least one DSM-IV diagnosis of
ED (Table 1). Considering the percentiles of EDRC com-
posite score, a “clinical risk” of ED was observed in
13.3% of the sample.
DEPS-R and EDI-3 scores and EDs according to DSM-IV
and DSM-5 criteria relating to gender
Females showed significantly higher scores at DEPS-R
(median = 14) in relation to males (median = 10) (Table 1).
Similarly, a significant higher percentage of females met cri-
teria for at least one DSM-5 or DSM-IV diagnosis of ED
(33% and 17.5% respectively), than that observed in men
(11.1% and 8.3% respectively) (Table 1). Based on the per-
centiles of EDRC composite score and of “Drive for Thin-
ness” and “Body Dissatisfaction” scales, a “clinical risk” for
ED was detected in a higher percentage of females (22.3%,
21,4% and 28.2% respectively) compared to males (4.67%,
4.67% and 7.48% respectively) (CI = 0.087–0.27, p = 0.0001;
CI = 0.078, p = 0.0001; CI = 0.106–0.307, p = 0.0001 re-
spectively). No statistically significant gender difference was
observed in prevalence of “clinical risk” at “Bulimia”.
DEPS-R score relating to ED diagnosis according to DSM-IV
and DSM-5 criteria
Subjects who met criteria for at least one DSM-5 or
DSM-IV diagnosis of ED obtained significantly higher
scores at DEPS-R (median = 22 and 21 respectively), com-
pared to subjects without an ED diagnosis (median = 10)
(p < 0.0001).
Confirmatory factor analysis
To retest construct validity of the Italian version of
DEPS-R, a Confirmatory Factor analysis was performed
(Tables 2, 3; Fig. 1). The latent structure of subscales
was found to fully conform to that reported by Wisting
et al. [32] during validation of the original scale. Indeed,
the 3 latent factors relating to dimensions “maladaptive
eating habits” (factor 1), “preoccupation with thinness or
weight” (factor 2), and “concept of maintaining high
blood glucose values to lose weight” (factor 3) were all
confirmed (Table 2) [32]. All λx structural parameters
were significantly different from zero in the respective t-
tests performed (Table 2). Figure 1 illustrates the path-
diagram of the factorial solution obtained. Similar to
previous findings [32], the latent dimensions of DEPS-R
Table 1 Descriptive data
TOTAL MALE FEMALE p U di Mann-Whitney z-value I.C. 95%
SAMPLE 211 108 103
MEDIAN AGE (median) 38 38 38 0.74 5417.5
YEARS OF STUDY (median) 13 13 13 0.33 5142.0
BMI (median) 24 24 23 0.11 485.5
DEPS TOTAL(median) 12 10 14 0.004 4283.5
DSM-IV (perventage) 27 (12.8%) 9 (8.3%) 18 (17.5%) 0.0467 1.991 0.014 0.181
DSM-5 (perventage) 46 (21.8%) 12 (11.1%) 34 (33.0%) 0.00008 3.958 0.111 0.327
DIABETES TYPE I (perventage) 192 (91.0%) 97 (89.8%) 95 (92.2%) 0.54
DIABETES TYPE II (perventage) 19 (9.0%) 11 (10.2%) 8 (7.8%) 0.616 −0.053 0.101
Data are medians and percentages, p values refer to the significance of the difference between male and female (Mann-Whitney U-test and z-test respectively)
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these correlations failed to reach high values under any
condition (Fig. 1). Table 3 reports the main goodness of
fit statistics of the model. The results obtained by the
analysis demonstrate that the confirmatory factor ana-
lysis cannot be rejected in the light of the estimated
goodness of fit statistics of the model. Indeed, the relative
chi-square statistic, corrected for the degree of freedom of
the model, yields a score in line with the acceptability cri-
teria of the factorial solution (χ2/df = 250.83/101 = 2.48)
[39, 40]. Likewise, high scores are also obtained by the
other goodness of fit statistics, thus confirming the satis-
factory statistical validity of the factorial model (GFI = 0.87;
AGFI = 0.82; RMSEA = 0.085; FI = 0.85; NNFI = 0.88)
(Table 3). In this context, the high values yielded by coeffi-
cients of reproducibility of the factorial solution shouldTable 2 Confirmatory Factor structure of the Diabetes Eating Proble
D 14 (I feel that my eating is out of control)
D 3 (Other people have told me that my eating is out of control)
D 15 (I alternate between eating very little and eating huge amounts)
D12 (Other people tell me to take better care of my diabetes)
D 5 (I eat more when I am alone than when I am with others)
D 4 (When I overeat, I don’t take enough insulin to cover the food)
D 7 (I avoid checking my blood sugar when I feel like it is out of range)
D 2 (I skip meals and/or snacks)
D 13 (After I overeat, I skip my next insulin dose)
D 6 (I feel that it’s difficult to lose weight and control my diabetes at the sam
D 16 (I would rather be thin than to have good control of my diabetes)
D 1 (Losing weight is an important goal to me)
D11 (I feel fat when I take all of my insulin)
D 8 (I make myself vomit)
D 9 (I try to keep my blood sugar high so that I will lose weight)
D 10 (I try to eat to the point of spilling ketones in my urine)
Data represent pattern coefficientsalso be highlighted (CFI = 0.90; IFI = 0.90), thus demon-
strating the substantial stability of the structural parame-
ters of the model even in samples characterized by
different social and anagraphic characteristics, although
structurally homogenous to the sample on which DEPS-R
was originally validated under the constraint of configural
invariance of the factorial solution [40, 41].
Item-total correlations
The communality values (item-total correlations), means
and standard deviations for each item of DEPS-R are
listed in Table 4.
Test-retest reliability
Test-retest reliability revealed a high degree of reprodu-
cibility for DEPS-R: ICC = 0.950 (I.C 95%: 0.919–0.969).m Survey Revised - DEPS-R
F1 F2 F3
λx11 = 0.82
λx21 = 0.72
λx31 = 0.62
λx41 = 0.59
λx51 = 0.45
λx61 = 0.44
λx71 = 0.43
λx81 = 0.32
λx91 = 0.32
e time) λx12 = 0.68
λx22 = 0.61
λx32 = 0.60
λx42 = 0.59
λx13 = 0.75
λx23 = 0.54
λx33 = 0.44
Table 3 CFA Goodness of fit statistics
Degrees of Freedom = 101
Relative Chi-Square = 250.8.83/101 = 2.483
Root Mean Square Error of Approximation (RMSEA) = 0.085
90 Percent Confidence Interval for RMSEA = (0.072; 0.098)
Normed Fit Index (NFI) = 0.85
Non-Normed Fit Index (NNFI) = 0.88
Comparative Fit Index (CFI) = 0.90
Incremental Fit Index (IFI) = 0.90
Root Mean Square Residual (RMR) = 0.073
Goodness of Fit Index (GFI) = 0.87
Adjusted Goodness of Fit Index (AGFI) = 0.82
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Analysis of internal consistency of responses to each
single item of DEPS-R pointed out a good homogen-
eity for the scale (Cronbach’s Alpha = 0.83). Cron-
bach’s Alpha for the EDRC composite score at EDI-3
was 0.95.Fig. 1 Path-diagram of the factorial solutionConcurrent validity
Correlations between DEPS-R and EDI-3 are shown in
Table 5. A significant correlation was observed between
total scores obtained at DEPS-R, the 3 ED scales and the
EDRC at EDI-3. Factor 1, Factor 2 and Factor 3 correlated
significantly with both ED scales and EDRC at EDI-3.
Correlation of DEPS-R and EDRC with relevant clinical
variables
The DEPS-R total value positively correlated with BMI
median score in the sample as a whole and in males,
females, subjects with type 1 and subjects with type 2
diabetes (Table 6). The DEPS-R total value positively
correlated with HbA1C value in the sample as a whole
and in males, females and subjects with type 1 diabetes
(Table 6). No significant correlation with age, age of on-
set of diabetes, diabetes duration and number of injec-
tions of insulin per day was found. The EDRC score
positively correlated with BMI median score in the sam-
ple as a whole and in males, females and subjects with
type 1 diabetes (Table 6). No significant correlation with
age, HbA1C value, age of onset of diabetes, diabetes
Table 4 The communality value, the average and the standard deviation of each item of DEPS-R item statistics for total scale
Item-total r Mean Standard deviation
D 1 (Losing weight is an important goal to me) 0,68 2.21 1.809
D 2 (I skip meals and/or snacks) 0.26 1.22 1.256
D 3 (Other people have told me that my eating is out of control) 0.63 1.09 1.361
D 4 (When I overeat. I don’t take enough insulin to cover the food) 0.45 1.01 1.168
D 5 (I eat more when I am alone than when I am with others) 0.54 0.88 1.286
D 6 (I feel that it’s difficult to lose weight and control my diabetes at the same time) 0.6 1.55 1.652
D 7 (I avoid checking my blood sugar when I feel like it is out of range) 0.58 0.71 1.17
D 8 (I make myself vomit) 0.58 0.04 0.246
D 9 (I try to keep my blood sugar high so that I will lose weight) 0.44 0.12 0.494
D 10 (I try to eat to the point of spilling ketones in my urine) 0.62 0.03 0.205
D 11 (I feel fat when I take all of my insulin) 0.59 0.33 0.945
D 12 (Other people tell me to take better care of my diabetes) 0.54 1.85 1.607
D 13 (After I overeat. I skip my next insulin dose) 0.58 0.12 0.416
D 14 (I feel that my eating is out of control) 0.67 1.04 1.3
D 15 (I alternate between eating very little and eating huge amounts) 0.53 0.9 1.116
D 16 (I would rather be thin than to have good control of my diabetes) 0.56 0.46 1.105
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found (Table 6).
Incremental validity
To test incremental validity of DEPS-R versus EDI-3, a
general rating scale for EDs, represented by the EDRC
composite score, simple and multiple logistic regression
analysis was applied [37, 38], using diagnosis of ED ac-
cording to DSM-5 as dichotomous dependent variable,
and continuous variables represented by EDRC scores
achieved at DEPS-R, as predictors. The results obtained,
similar to observations made for the EDRC composite
score, demonstrated a high validity of DEPS-R scale in
predicting ED diagnosis, particularly in view of the
high statistical significance of comparability of mul-
tiple logistic regression parameters (Table 7). A par-
ameter of β1 = 0.0439 was estimated for the EDRC
variable (SE = 0.01450, p < 0.01), and a parameter of
β2 = 0.08105 (SE = 0.02712, p < 0.01) for the DEPS-Table 5 Correlation among scales
DEPS-R total Factor 1 Factor 2 Fac
1 DEPS-R total
2 Factor 1 0.925**
3 Factor 2 0.859** 0.671**
4 Factor 3 0.596** 0.437** 0.624**
7 Drive for thinness 0.631** 0.556** 0.698** 0.3
8 Bulimia 0.556** 0.591** 0.423** 0.3
9 Body dissatisfaction 0.525** 0.462** 0.613** 0.2
10 EDRC 0.673** 0.618** 0.715** 0.3
**p < 0.0001R variable. Moreover, a combined use of the two
scales was found to produce a synergic effect in pre-
dicting a diagnosis of ED, further reducing the risk of
detection of false negatives (Table 7).
Discussion
The main purpose of the present study was to validate
the Italian version of the DEPS-R scale, extending valid-
ation to a representative sample of insulin-treated male
and female subjects with type 1 and type 2 diabetes aged
from 13 to 55 years. The DEPS-R scale was first devel-
oped as a tool capable of rapidly screening for ED in a
pediatric population with type 1 diabetes, and is cur-
rently recognized as a good screening instrument in rec-
ognizing individuals at-risk for developing ED in this
patient population [1, 16, 29–32]. Considering the limi-
tations of previous studies, largely performed on adoles-
cents with type 1 diabetes, we decided to extend
investigations and validation of the questionnaire, intor 3 Drive for thinness Bulimia Body dissatisfaction EDRC
99**
33** 0.578**
06** 0.608** 0.392**
51** 0.866** 0.688** 0.89**
Table 6 Correlation of DEPS-R with relevant variables
DEPS-R EDCR
r (p) r (p)
Whole
cohort
Males Females Subject with
type 1 diabetes
Subject with
type 2 diabetes
Whole
cohort
Males Females Subject with
type 1 diabetes
Subject with
type 2 diabetes
Age −0.037
(0.593)
−0.037
(0.593)
−0.102
(0.304)
−0.076 (0.295) −0.422 (0.072) 0.018
(0.798)
0.047
(0.632)
−0.175
(0.077)
−0.143 (0.049) −0.443 (0.065)
BMI 0.408
(0.000)
0.408
(0.000)
0.457
(0.000)
0.345 (0.000) 0.593 (0.007) 0.405
(0.000)
0.412
(0.000)
0.464
(0.000)
0.391 (0.000) 0.326 (0.187)
HbA1C 0.225
(0.001)
0.225
(0.001)
0.243
(0.014)
0.216 (0.003) 0.238 (0.341) 0.91
(0.193)
0.168
(0.088)
0.097
(0.332)
0.098 (0.178) −0.08 (0.76)
Diabetes Age
of onset
−0.012
(0.863)
−0.012
(0.863)
0.02
(0.843)
−0.054 (0.453) −0.239 (0.325) −0.044
(0.527)
−0.017
(0.865)
−0.042
(0.671)
−0.117 (0.107) −0.223 (0.373)
Diabetes
duration
−0.023
(0.738)
−0.023
(0.738)
−0.122
(0.22)
−0.014 (0.842) 0.075 (0.762) 0.068
(0.325)
0.074
(0.449)
−0.124
(0.211)
−0.012 (0.865) 0.043 (0.866)
Number of
injections of
insulin per day
−0.09
(0.242)
−0.077
(0.487)
−0.122
(0.264)
0.084 (0.307) −0.364 (0.126) −0.042
(0.586)
−0.003
(0.976)
−0.104
(0.343)
0.089 (0.281) −0.279 (0.263)
In bracketes the level of significativity
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sentative sample of insulin-treated diabetic subjects in-
cluding individuals with type 2 diabetes and adults.
Indeed, although literature data relating to ED and DEB
in diabetic patients focus largely on subjects with type 1
diabetes [4–13], ED would seem to impinge heavily also
on subjects with type 2 diabetes [8, 14]. At the same
time, although these disorders are manifested largely
during adolescence, they frequently persist, particularly
if left untreated, into adulthood [5]. The lack of studies
conducted on a population of adult diabetic subjects
moreover increases the risk of an underestimation and
under-diagnosis of the majority of cases of ED in this
population [16]. Taking into account the high prevalence
and implications of comorbidity between diabetes and
EDs, the singular means of manifestation of EDs in
diabetic subjects, and the diagnostic limitations of trad-
itional questionnaires in this patient population, the
availability of specific screening tools of proven validity
is fundamental in ensuring an early identification of the
disorder and timely administration of treatment.
Overall, 21.8% of the sample studied, 33% of females
and 11.1% of males, met the criteria for at least one
diagnosis of ED according to DSM-5, including in this
percentage the “Unspecified EDs and Other Specified
EDs”. A lower percentage, 12.8% of the total sample,Table 7 Multiple Logistic Regression of EDRC and DEPS-R vs
Diagnosis of ED according to DSM-5 criteria
Estimate Std.Error zvalue Pr(>|z|)
(Intercept) −3.74132 0.47591 −7.861 3.8e-15***
EDRC 0.04397 0.01450 3.032 0.00243**
DEPS-R 0.08105 0.02712 2.989 0.00280**
***p < 0.0001
**p < 0.00117.5% of females and 8.3% of males, met the criteria for
at least one diagnosis of ED according to DSM-IV, in-
cluding “ED Not Otherwise Specified”. This finding of
different rates of prevalence of EDs according to criteria
adopted by DSM-IV or DSM-5, is in agreement with
recent data from literature highlighting, in general, an
increased ability of DSM-5 criteria to identify the pres-
ence of an ED, in addition to the acknowledged ability,
linked to the higher degree of inclusivity of the diagnos-
tic criteria, to formulate a “specified ED diagnosis”, thus
reducing the rate of “non – specified ED diagnosis” [34].
The high prevalence of EDs identified at EDI-3 in the
sample studied, is in agreement with data from literature
reporting a high prevalence of EDs and DEB in diabetic
patients, with rates exceeding those observed in the general
population, and which vary according to the characteristics
of the sample, to the rating tools applied and to the criteria
used to formulate a diagnosis [1, 4, 6, 7, 13, 15]. ED preva-
lence rates according to DSM-5 are moreover higher com-
pared to the rates of clinical risk of ED reported at EDI-3,
thus highlighting the increased ability of a structured inter-
view such as the amended version of module H of SCID-1,
to identify cases of ED compared to those detected using a
self-administered tool lacking specificity for the assessment
of EDs in diabetes. In our sample a significantly higher
prevalence of ED according to criteria adopted by DSM-IV
and DSM-5, a significantly increased risk of ED at EDI-3,
and higher scores at DEPS-R were found amongst females.
Accordingly, there is a consensus in literature establishing
that females, both adolescents and adults, have a higher
prevalence and an increased risk of ED even if prevalence
remains relatively high amongst males [42, 43]. A possible
hypothesis advanced for this discrepancy may be attributed
to the diagnostic criteria applied, which fail to consider the
specific gender-related symptoms of ED, for example the
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over, the fact that the majority of ED studies have been
conducted on exclusively, or prevalently, female samples,
tends to complicate or even contradict the picture of
clinical characteristics of males with ED, thus hampering
identification of these disorders [45]. The higher scores
obtained at DEPS-R by females are in agreement with
the findings of previous studies conducted to validate
the scale [29, 31, 32].
The Italian version of DEPS-R displayed an adequate
degree of structural stability even in different linguistic
and social settings (Table 3). The latent structure of sub-
scales was found to fully conform to the latent dimen-
sions referred for factors 1 2 and 3 by Wisting et al. [32].
Indeed, the three latent factors relating to dimensions
“maladaptive eating habits” (factor 1), “preoccupation
with thinness or weight” (factor 2), and “concept of
maintaining high blood glucose values to lose weight”
(factor 3) were all confirmed [32] (Table 2). Overall, the
Italian version of the scale demonstrated a good degree
of reliability, a good homogeneity and a good reproduci-
bility, confirming the good psychometric properties of
the original version, with the addiction of test-retest reli-
ability assessment, which was not contemplated for the
English version. Moreover, in this study, analysis of the
DEPS-R scale in relation to EDI-3, a specific tool for the
assessment of ED, and the use of a structured clinical
interview, H module of SCID-1 and amended H module,
allowed us to overcome some of the more significant
limitations of previous validation studies.
Markowitz et al. [29] validated DEPS-R in a pediatric
sample of boys and girls with type 1 diabetes, obtaining
a good internal consistency and good construct validity
by means of comparison with areas that may be affected
by the presence of a DEB (positive correlation with age,
BMI standardized for age, sex and hemoglobin A1C), in
addition to a good external validity based on clinicians’
reports of insulin restriction in their patients. In the au-
thors’ opinion, one of the main limitations of the study
was the lack of comparison with a specific rating tool for
ED, the small sample size (112 youths), and the age
range of the sample (13–19 years), which were not suffi-
cient to allow results to be generalized to other age
groups [29]. Two years later, in extending validation
of the scale to a larger sample of 770 young patients
(11–19 years) with type 1 diabetes, Wisting et al. [32] re-
vealed a good correlation of DEPS-R with the Eating Atti-
tudes Test – (EAT-12), a general rating tool for EDs. A
study conducted to validate the German version of the
scale was carried out on 246 subjects with type 1 diabetes
(11–19 years), showing a good internal consistency and a
good construct validity for the scale, with a significant cor-
relation between DEPS-R and two general screening tools
for ED (SCOFF and the Eating Disorder ExaminationQuestionnaire – EDE-Q) [31]. Similar to the findings of
Wisting et al. and Saßmann et al. [31, 32], the DEPS-R
scale also displayed a good concurrent validity in our
study. Namely, a significant correlation was seen between
total score at DEPS-R and the 3 ED risk scales of
EDI-3 (“Body dissatisfaction”, “Drive for Thinness”
and “Bulimia”) and between DEPS-R and score obtained
at EDRC. Factors 1, 2 and 3 of DEPS-R were found to cor-
relate with both ED risk scales and with EDRC score. In-
deed, based on scores at EDI-3, subjects with a higher
score at DEPS-R were characterized by more disturbed
eating behaviors and increasing concerns about eating and
body image. At the same time, subjects who met criteria
for the diagnosis of at least one ED according to DSM-IV
and/or DSM-5 achieved significantly higher mean scores
at DEPS-R compared to subjects without this diagnosis.
This finding highlights the ability of the scale to identify
both subjects at risk of ED and subjects affected by full-
blown ED.
Accordingly, incremental validity analysis for DEPS-R
versus EDI-3 revealed the high validity of DEPS-R in
predicting a diagnosis of ED in line with DSM-5 criteria,
highlighting how use of this tool in combination with
EDI-3 would produce a synergic effect in predicting
diagnosis of ED, thus reducing the risk of detection of
false negatives (Table 7). In support of the added value
provided by this tool for the investigation of EDs in
subjects affected by diabetes, the brevity of the scale,
making it easy to use in a clinical setting, and the correl-
ation of DEPS-R scores with metabolic imbalance in dia-
betic patients, should be underlined (Table 6). Higher
score at DEPS-R was significantly related to higher
HbA1C value and BMI median score in the sample as a
whole and in males, females and subjects with type 1
diabetes, whereas the correlation between the EDRC
score and the HbA1C was not significant. These results,
in line with those reported by Saßmann et al., support
the utility of the DEPS-R, a specific screening tool, to
detect unhealthy practices of weight control leading to
poor metabolic control in people with insulin treated
diabetes [31].
Moreover, the higher representativeness of the sample
in terms of age, following extension of the study to in-
clude subjects aged from 13 to 55 years, would appear
to promote extension of validity of the questionnaire to
larger samples of adolescent and adult patients affected
by insulin-treated diabetes. Overall, the paucity of sub-
jects with type 2 diabetes, respect to those affected by
type 1 diabetes, does not allow the extension of the val-
idation of the scale to this group. However, the signifi-
cant more representation in this study of subjects
affected by type 1 diabetes, respect to those affected by
type 2 diabetes, reflects what is generally observed in
clinical samples of insulin-treated subjects. In fact while
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treated with insulin, the treatment of type 2 diabetic pa-
tients include insulin only when strategies such as weight
reduction, diet and oral medications fail to control
diabetes. A further extension of the study to a larger group
of patients affected by type 2 diabetes would be required
to confirm extension of the validity of the scale to this
diagnostic group.
The data should be interpreted in the light of several
limitations, including the absence of an untreated sample
of diabetic patients and the absence of a non-diabetic
sample as control groups and the paucity of subjects with
type 2 diabetes that does not allow the extension of the
validation of the scale to this group.
Conclusions
In conclusion, the present study conducted on a repre-
sentative sample of insulin-treated adolescent and adult
patients with both type 1 and type 2 diabetes, confirms
the reliability and validity of the Italian version of the
DEPS-R scale, showing a good construct validity, a good
internal consistency, and a good degree of reproducibil-
ity. Analysis of the scale in relation to EDI-3, a specific
tool used to assess EDs, and accompanied by use of a
structured clinical interview in the diagnosis of ED, has
highlighted the ability of the scale to identify both subjects
at risk of ED and those affected by full-blown ED. In view
of the significance and implications of EDs in patients af-
fected by diabetes, with the associated health risks and
singular presentation of EDs that render the results ob-
tained by traditional ED screening tools unreliable, the
availability of specific screening tools of proven validity is
crucial to ensure a correct and rapid clinical-diagnostic
classification and timely treatment of this co-morbidity.
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